U. Matulonis
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- PARP inhibition in cancer therapy
- Vascular Tumors and Angiosarcomas
- CAR-T cell therapy research
Papers in
- Oncology 23
- HER2/EGFR in Cancer Research 6
- Cancer Treatment and Pharmacology 5
- PARP inhibition in cancer therapy 4
-
- Ovarian cancer diagnosis and treatment 14
- Co-authors
- Chrysoula Dosiou (1 shared paper)JD Griffin (1 shared paper)Christine Lamont (1 shared paper)P Mauch (1 shared paper)GJ Freeman (1 shared paper)LM Nadler (1 shared paper)Michael V. Seiden (4 shared papers)Geraldine Goss (1 shared paper)
- Journals
- Journal of Clinical Oncology (16 papers)Gynecologic Oncology (6 papers)Annals of Oncology (5 papers)Clinical Infectious Diseases (2 papers)Blood (1 paper)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
U. Matulonis
31 papers receiving 595 citations
Peers
Comparison fields: 5 of 53
- Reproductive Medicine 105
- Oncology 289
- Pulmonary and Respiratory Medicine 231
- Immunology 113
- Obstetrics and Gynecology 38
Countries citing papers authored by U. Matulonis
This map shows the geographic impact of U. Matulonis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Matulonis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Matulonis more than expected).
Fields of papers citing papers by U. Matulonis
This network shows the impact of papers produced by U. Matulonis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Matulonis. The network helps show where U. Matulonis may publish in the future.
Co-authors
The 25 scholars most cited alongside U. Matulonis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 259 | |
| 2 | 1995 | 112 | |
| 3 | 2011 | 49 | |
| 4 | 2006 | 46 | |
| 5 | 2011 | 30 | |
| 6 | 2007 | 20 | |
| 7 | 2019 | 16 | |
| 8 | 2018 | 12 | |
| 9 | 2018 | 11 | |
| 10 | 2005 | 8 | |
| 11 | 2022 | 5 | |
| 12 | 2019 | 5 | |
| 13 | 1999 | 5 | |
| 14 | 2009 | 4 | |
| 15 | 2012 | 4 | |
| 16 | 2010 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2011 | 4 | |
| 19 | 2008 | 3 | |
| 20 | 2006 | 2 |
About U. Matulonis
U. Matulonis is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 34 papers that have together received 617 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers), PARP inhibition in cancer therapy (4 papers), Cancer Genomics and Diagnostics (2 papers), BRCA gene mutations in cancer (2 papers), Advanced Breast Cancer Therapies (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Reproductive Medicine (105 citations), Oncology (289 citations), Pulmonary and Respiratory Medicine (231 citations), Immunology (113 citations) and Obstetrics and Gynecology (38 citations). U. Matulonis has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Chrysoula Dosiou, JD Griffin, Christine Lamont, P Mauch, GJ Freeman, LM Nadler, Michael V. Seiden, Geraldine Goss, Priscilla Merriam and Jennifer Canniff. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Annals of Oncology, Clinical Infectious Diseases and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.